Literature DB >> 23047559

Promoter-proximal CCCTC-factor binding is associated with an increase in the transcriptional pausing index.

Sur Herrera Paredes1, Michael F Melgar, Praveen Sethupathy.   

Abstract

MOTIVATION: It has been known for more than 2 decades that after RNA polymerase II (RNAPII) initiates transcription, it can enter into a paused or stalled state immediately downstream of the transcription start site before productive elongation. Recent advances in high-throughput genomic technologies facilitated the discovery that RNAPII pausing at promoters is a widespread physiologically regulated phenomenon. The molecular underpinnings of pausing are incompletely understood. The CCCTC-factor (CTCF) is a ubiquitous nuclear factor that has diverse regulatory functions, including a recently discovered role in promoting RNAPII pausing at splice sites.
RESULTS: In this study, we analyzed CTCF binding sites and nascent transcriptomic data from three different cell types, and found that promoter-proximal CTCF binding is significantly associated with RNAPII pausing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23047559      PMCID: PMC3673211          DOI: 10.1093/bioinformatics/bts596

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  20 in total

1.  Identification of transcription factor binding sites in the human genome sequence.

Authors:  Samuel Levy; Sridhar Hannenhalli
Journal:  Mamm Genome       Date:  2002-09       Impact factor: 2.957

2.  CTCF-dependent chromatin insulator as a built-in attenuator of angiogenesis.

Authors:  Jianrong Lu; Ming Tang
Journal:  Transcription       Date:  2012-03-01

3.  The meaning of pausing.

Authors:  Joaquín M Espinosa
Journal:  Mol Cell       Date:  2010-11-24       Impact factor: 17.970

4.  Transcriptional pausing without backtracking.

Authors:  Robert Landick
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-26       Impact factor: 11.205

5.  Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters.

Authors:  Leighton J Core; Joshua J Waterfall; John T Lis
Journal:  Science       Date:  2008-12-04       Impact factor: 47.728

6.  Regulating RNA polymerase pausing and transcription elongation in embryonic stem cells.

Authors:  Irene M Min; Joshua J Waterfall; Leighton J Core; Robert J Munroe; John Schimenti; John T Lis
Journal:  Genes Dev       Date:  2011-04-01       Impact factor: 11.361

7.  c-Myc regulates transcriptional pause release.

Authors:  Peter B Rahl; Charles Y Lin; Amy C Seila; Ryan A Flynn; Scott McCuine; Christopher B Burge; Phillip A Sharp; Richard A Young
Journal:  Cell       Date:  2010-04-30       Impact factor: 41.582

8.  mRNA decapping factors and the exonuclease Xrn2 function in widespread premature termination of RNA polymerase II transcription.

Authors:  Kris Brannan; Hyunmin Kim; Benjamin Erickson; Kira Glover-Cutter; Soojin Kim; Nova Fong; Lauren Kiemele; Kirk Hansen; Richard Davis; Jens Lykke-Andersen; David L Bentley
Journal:  Mol Cell       Date:  2012-04-05       Impact factor: 17.970

Review 9.  Promoter proximal pausing and the control of gene expression.

Authors:  Jian Li; David S Gilmour
Journal:  Curr Opin Genet Dev       Date:  2011-02-14       Impact factor: 5.578

Review 10.  Does CTCF mediate between nuclear organization and gene expression?

Authors:  Rolf Ohlsson; Victor Lobanenkov; Elena Klenova
Journal:  Bioessays       Date:  2010-01       Impact factor: 4.345

View more
  20 in total

1.  RNA Pol II transcription model and interpretation of GRO-seq data.

Authors:  Manuel E Lladser; Joseph G Azofeifa; Mary A Allen; Robin D Dowell
Journal:  J Math Biol       Date:  2016-05-03       Impact factor: 2.259

Review 2.  CTCF: an architectural protein bridging genome topology and function.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  Nat Rev Genet       Date:  2014-03-11       Impact factor: 53.242

Review 3.  KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer.

Authors:  Besa Xhabija; Benjamin L Kidder
Journal:  Semin Cancer Biol       Date:  2018-11-16       Impact factor: 15.707

Review 4.  Human telomerase reverse transcriptase regulation by DNA methylation, transcription factor binding and alternative splicing (Review).

Authors:  Brittany A Avin; Christopher B Umbricht; Martha A Zeiger
Journal:  Int J Oncol       Date:  2016-10-20       Impact factor: 5.650

Review 5.  Enhancer-gene specificity in development and disease.

Authors:  Tomás Pachano; Endika Haro; Alvaro Rada-Iglesias
Journal:  Development       Date:  2022-06-10       Impact factor: 6.862

6.  JARID1B is a luminal lineage-driving oncogene in breast cancer.

Authors:  Shoji Yamamoto; Zhenhua Wu; Hege G Russnes; Shinji Takagi; Guillermo Peluffo; Charles Vaske; Xi Zhao; Hans Kristian Moen Vollan; Reo Maruyama; Muhammad B Ekram; Hanfei Sun; Jee Hyun Kim; Kristopher Carver; Mattia Zucca; Jianxing Feng; Vanessa Almendro; Marina Bessarabova; Oscar M Rueda; Yuri Nikolsky; Carlos Caldas; X Shirley Liu; Kornelia Polyak
Journal:  Cancer Cell       Date:  2014-06-16       Impact factor: 31.743

Review 7.  Chromatin insulators: linking genome organization to cellular function.

Authors:  Jennifer E Phillips-Cremins; Victor G Corces
Journal:  Mol Cell       Date:  2013-05-23       Impact factor: 17.970

Review 8.  Mechanisms of cohesin-mediated gene regulation and lessons learned from cohesinopathies.

Authors:  Alexander R Ball; Yen-Yun Chen; Kyoko Yokomori
Journal:  Biochim Biophys Acta       Date:  2013-11-22

Review 9.  Regulation of RNA Polymerase II Transcription Initiation and Elongation by Transcription Factor TFII-I.

Authors:  Niko Linzer; Alexis Trumbull; Rukiye Nar; Matthew D Gibbons; David T Yu; John Strouboulis; Jörg Bungert
Journal:  Front Mol Biosci       Date:  2021-05-13

Review 10.  DNA modifications: function and applications in normal and disease States.

Authors:  Vichithra R B Liyanage; Jessica S Jarmasz; Nanditha Murugeshan; Marc R Del Bigio; Mojgan Rastegar; James R Davie
Journal:  Biology (Basel)       Date:  2014-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.